Yes, tirzepatide is available in various dosage options, namely 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, all in a 0.5 mL volume
Whether you are researching semaglutide vs tirzepatide or comparing them the other way around, the clinical data points in one direction tirzepatide produces greater average weight loss
Wegovy (semaglutide for weight management) Available doses: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg weekly
This was not a marginal finding
Decreased appetite is technically a side effect (reported by 5-9%) though most patients consider it the desired therapeutic effect
(While not unique to compounded drugs, the FDA also permits some unapproved prescription drugs to be marketed when health care professionals rely on the drug to treat serious medical conditions and there is no FDA-approved option.) However, with regard to the Willow post, its worth noting that GLP-1 drugs have only been approved to treat diabetes or weight loss, not alcohol problems